APYX - Latest News
Apyx Medical Corporation (APYX), operates in Healthcare / Medical - Devices, trades on NASDAQ.
Market capitalization stands near $160.8M. Beta to the broader market is 1.35.
The article list below shows the most recent APYX headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.
Recent APYX Headlines
Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction
globenewswire.com - May 14, 2026
CLEARWATER, Fla. , May 14, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company” or “Apyx Medical”), the leader in surgical a
Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™
globenewswire.com - May 11, 2026
Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON Additi
Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript
seekingalpha.com - May 7, 2026
Apyx Medical Corporation (APYX) Q1 2026 Earnings Call Transcript
Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates
zacks.com - May 7, 2026
Apyx Medical (APYX) came out with a quarterly loss of $0. 05 per share versus the Zacks Consensus Estimate of a loss of $0.
Apyx Medical Corporation Reports First Quarter 2026 Financial Results
globenewswire.com - May 7, 2026
CLEARWATER, Fla. , May 07, 2026 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (“Apyx Medical;” the “Company”), the leader in surgical aes
How News Affects APYX Options Pricing
Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track APYX's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.
Frequently asked APYX news questions
- What is the latest APYX news headline?
- The most recent APYX headline (May 14, 2026) is "Apyx Medical Corporation Announces Retrospective Clinical Publication Evaluating Clinical Benefit of Renuvion® Used in Combination with Liposuction". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
- How fresh is the APYX news on this page?
- News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
- What APYX news moves options pricing?
- Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
- How can I track unusual APYX options activity related to news?
- Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.